ctDNA analysis based on methylation of three of these genes (ST6GALNAC3, CCDC181, and HAPLN3) could detect prostate cancer with 100% diagnostic specificity and 67% diagnostic sensitivity [51]. This evidence concerns the gene HAPLN3 and prostate carcinoma.